June 19, 2018
1616 Rhode Island Ave. NW
Washington, DC 20036
Adam Berger, Ph.D.
Senior Staff Fellow, Personalized Medicine
Office of In Vitro Diagnostics and Radiological Health
Center for Devices and Radiological Health
U.S. Food and Drug Administration
Registration (Members Only):
Adam Berger, Ph.D., Senior Staff Fellow, Personalized Medicine, U.S. Food and Drug Administration (FDA), will join us to discuss the agency's efforts to develop a regulatory structure for digital health technologies that may help facilitate personalized care regimens.
During the business portion of the meeting, which will follow our conversation with Berger, we will examine PMC's progress on its Strategic Plan for 2018. We will discuss, among other topics, the Coalition's plans to study the clinical and economic utility of whole exome sequencing for patients with rare and undiagnosed diseases and to update its Introduction to Informational Genetic Testing, a consumer guide to DNA-based health information testing originally published in 2008.
Please contact Christopher Wells, Vice President, Public Affairs, Personalized Medicine Coalition, at firstname.lastname@example.org for more information about PMC's member-only Policy Committee meetings.